Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report

Alzheimer's Disease (AD) is a neurodegenerative progressive disorder for which there is currently no cure.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report a case study of a 59-year-old man with mild Alzheimer's disease and type 2 diabetes who followed a 10-week ketogenic nutrition protocol combined with transcranial photobiomodulation. They report improved metabolic markers and a cognitive score change on the MoCA. As a single-patient case report without a control group, these findings cannot establish whether the intervention caused the changes.

Participants
1
Who or what was studied
A single 59-year-old male with mild Alzheimer's disease, heterozygous ApoE4 carrier, and an 11-year history of insulin-dependent type 2 diabetes
Limits stated in the abstract
Single case report with one participant and no control group, so causality and generalizability cannot be established.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Mild cognitive impairment, Mitochondria, Case report, Montreal Cognitive Assessment, Near-infrared, Transcranial photobiomodulation. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Brain & Neurology

Chronic 40-hz light-emitting diode (LED) therapy attenuates cognitive and behavioral deficits and modulates BDNF and caspase-3 expression in a D-galactose/aluminum chloride-induced sporadic Alzheimer's-like rat model

These data suggest that 40-Hz LED stimulation confers neuroprotection in the D-gal/AlCl3-induced AD model, potentially through enhancement of neurotropic signaling and inhibition of apoptosis, supporting its promise as a non-invasive strategy against neurodegenerative decline.

Study · August 7, 2026 · Ghorbani E et al.